SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028844
Filing Date
2018-11-09
Accepted
2018-11-09 13:45:05
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q insy-10q_20180930.htm 10-Q 3041555
2 EX-31.1 insy-ex311_7.htm EX-31.1 9134
3 EX-31.2 insy-ex312_8.htm EX-31.2 9015
4 EX-32 insy-ex32_6.htm EX-32 9124
  Complete submission text file 0001564590-18-028844.txt   13469411

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT insy-20180930.xml EX-101.INS 4105696
6 XBRL TAXONOMY EXTENSION SCHEMA insy-20180930.xsd EX-101.SCH 52949
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20180930_cal.xml EX-101.CAL 54225
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20180930_def.xml EX-101.DEF 200202
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20180930_lab.xml EX-101.LAB 408335
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20180930_pre.xml EX-101.PRE 360129
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 181172334
SIC: 2834 Pharmaceutical Preparations